Explore › Condition › Age-related cognitive decline
Condition

Age-related cognitive decline

Also known as: Age-related cognitive decline Age-related cognitive decline (finding) cognitive decline; coronary atherosclerosis
3 findings 1 paper 3 related entities View in graph →

Related entities

interventions
Mental stress-induced myocardial ischemia1
outcomes
Executive Function1
studys
PMC78576481

Findings (27)

None
decline

Presence of MSIMI at baseline was associated with 33% greater increase in Trail-B score over 2 years of follow-up, indicating faster executive function decline, and this association was partly mediate

Effect: decline; B 0.33; CI: 95% CI 0.04, 0.62

Size: B 0.33 CI: 95% CI 0.04, 0.62
PMC7857648
Finding details → · Paper → · Graph →
None
decline

Presence of MSIMI at baseline was associated with 33% greater increase in Trail-B score over 2 years of follow-up, indicating faster executive function decline, and this association was partly mediate

Effect: decline; B 0.33; CI: 95% CI 0.04, 0.62

Size: B 0.33 CI: 95% CI 0.04, 0.62
PMC7857648
Finding details → · Paper → · Graph →
None
decline

Presence of MSIMI at baseline was associated with 33% greater increase in Trail-B score over 2 years of follow-up, indicating faster executive function decline, and this association was partly mediate

Effect: decline; B 0.33; CI: 95% CI 0.04, 0.62

Size: B 0.33 CI: 95% CI 0.04, 0.62
PMC7857648
Finding details → · Paper → · Graph →
None
decline

Presence of MSIMI at baseline was associated with 33% greater increase in Trail-B score over 2 years of follow-up, indicating faster executive function decline, and this association was partly mediate

Effect: decline; B 0.33; CI: 95% CI 0.04, 0.62

Size: B 0.33 CI: 95% CI 0.04, 0.62
PMC7857648
Finding details → · Paper → · Graph →
None
decline

Presence of MSIMI at baseline was associated with 33% greater increase in Trail-B score over 2 years of follow-up, indicating faster executive function decline, and this association was partly mediate

Effect: decline; B 0.33; CI: 95% CI 0.04, 0.62

Size: B 0.33 CI: 95% CI 0.04, 0.62
PMC7857648
Finding details → · Paper → · Graph →
None
decline

Presence of MSIMI at baseline was associated with 33% greater increase in Trail-B score over 2 years of follow-up, indicating faster executive function decline, and this association was partly mediate

Effect: decline; B 0.33; CI: 95% CI 0.04, 0.62

Size: B 0.33 CI: 95% CI 0.04, 0.62
PMC7857648
Finding details → · Paper → · Graph →
None
decline

Presence of MSIMI at baseline was associated with 33% greater increase in Trail-B score over 2 years of follow-up, indicating faster executive function decline, and this association was partly mediate

Effect: decline; B 0.33; CI: 95% CI 0.04, 0.62

Size: B 0.33 CI: 95% CI 0.04, 0.62
PMC7857648
Finding details → · Paper → · Graph →
None
decline

Presence of MSIMI at baseline was associated with 33% greater increase in Trail-B score over 2 years of follow-up, indicating faster executive function decline, and this association was partly mediate

Effect: decline; B 0.33; CI: 95% CI 0.04, 0.62

Size: B 0.33 CI: 95% CI 0.04, 0.62
PMC7857648
Finding details → · Paper → · Graph →
None
decline

Presence of MSIMI at baseline was associated with 33% greater increase in Trail-B score over 2 years of follow-up, indicating faster executive function decline, and this association was partly mediate

Effect: decline; B 0.33; CI: 95% CI 0.04, 0.62

Size: B 0.33 CI: 95% CI 0.04, 0.62
PMC7857648
Finding details → · Paper → · Graph →
None
decline

Presence of MSIMI at baseline was associated with 33% greater increase in Trail-B score over 2 years of follow-up, indicating faster executive function decline, and this association was partly mediate

Effect: decline; B 0.33; CI: 95% CI 0.04, 0.62

Size: B 0.33 CI: 95% CI 0.04, 0.62
PMC7857648
Finding details → · Paper → · Graph →
None
decline

Presence of MSIMI at baseline was associated with 33% greater increase in Trail-B score over 2 years of follow-up, indicating faster executive function decline, and this association was partly mediate

Effect: decline; B 0.33; CI: 95% CI 0.04, 0.62

Size: B 0.33 CI: 95% CI 0.04, 0.62
PMC7857648
Finding details → · Paper → · Graph →
None
decline

Presence of MSIMI at baseline was associated with 33% greater increase in Trail-B score over 2 years of follow-up, indicating faster executive function decline, and this association was partly mediate

Effect: decline; B 0.33; CI: 95% CI 0.04, 0.62

Size: B 0.33 CI: 95% CI 0.04, 0.62
PMC7857648
Finding details → · Paper → · Graph →
None
decline

Presence of MSIMI at baseline was associated with 33% greater increase in Trail-B score over 2 years of follow-up, indicating faster executive function decline, and this association was partly mediate

Effect: decline; B 0.33; CI: 95% CI 0.04, 0.62

Size: B 0.33 CI: 95% CI 0.04, 0.62
PMC7857648
Finding details → · Paper → · Graph →
None
decline

Presence of MSIMI at baseline was associated with 33% greater increase in Trail-B score over 2 years of follow-up, indicating faster executive function decline, and this association was partly mediate

Effect: decline; B 0.33; CI: 95% CI 0.04, 0.62

Size: B 0.33 CI: 95% CI 0.04, 0.62
PMC7857648
Finding details → · Paper → · Graph →
None
decline

Presence of MSIMI at baseline was associated with 33% greater increase in Trail-B score over 2 years of follow-up, indicating faster executive function decline, and this association was partly mediate

Effect: decline; B 0.33; CI: 95% CI 0.04, 0.62

Size: B 0.33 CI: 95% CI 0.04, 0.62
PMC7857648
Finding details → · Paper → · Graph →
None
decline

Presence of MSIMI at baseline was associated with 33% greater increase in Trail-B score over 2 years of follow-up, indicating faster executive function decline, and this association was partly mediate

Effect: decline; B 0.33; CI: 95% CI 0.04, 0.62

Size: B 0.33 CI: 95% CI 0.04, 0.62
PMC7857648
Finding details → · Paper → · Graph →
None
decline

Presence of MSIMI at baseline was associated with 33% greater increase in Trail-B score over 2 years of follow-up, indicating faster executive function decline, and this association was partly mediate

Effect: decline; B 0.33; CI: 95% CI 0.04, 0.62

Size: B 0.33 CI: 95% CI 0.04, 0.62
PMC7857648
Finding details → · Paper → · Graph →
None
decline

Presence of MSIMI at baseline was associated with 33% greater increase in Trail-B score over 2 years of follow-up, indicating faster executive function decline, and this association was partly mediate

Effect: decline; B 0.33; CI: 95% CI 0.04, 0.62

Size: B 0.33 CI: 95% CI 0.04, 0.62
PMC7857648
Finding details → · Paper → · Graph →
None
decline

Presence of MSIMI at baseline was associated with 33% greater increase in Trail-B score over 2 years of follow-up, indicating faster executive function decline, and this association was partly mediate

Effect: decline; B 0.33; CI: 95% CI 0.04, 0.62

Size: B 0.33 CI: 95% CI 0.04, 0.62
PMC7857648
Finding details → · Paper → · Graph →
None
decline

Presence of MSIMI at baseline was associated with 33% greater increase in Trail-B score over 2 years of follow-up, indicating faster executive function decline, and this association was partly mediate

Effect: decline; B 0.33; CI: 95% CI 0.04, 0.62

Size: B 0.33 CI: 95% CI 0.04, 0.62
PMC7857648
Finding details → · Paper → · Graph →
None
decline

Presence of MSIMI at baseline was associated with 33% greater increase in Trail-B score over 2 years of follow-up, indicating faster executive function decline, and this association was partly mediate

Effect: decline; B 0.33; CI: 95% CI 0.04, 0.62

Size: B 0.33 CI: 95% CI 0.04, 0.62
PMC7857648
Finding details → · Paper → · Graph →
None
decline

Presence of MSIMI at baseline was associated with 33% greater increase in Trail-B score over 2 years of follow-up, indicating faster executive function decline, and this association was partly mediate

Effect: decline; B 0.33; CI: 95% CI 0.04, 0.62

Size: B 0.33 CI: 95% CI 0.04, 0.62
PMC7857648
Finding details → · Paper → · Graph →
None
decline

Presence of MSIMI at baseline was associated with 33% greater increase in Trail-B score over 2 years of follow-up, indicating faster executive function decline, and this association was partly mediate

Effect: decline; B 0.33; CI: 95% CI 0.04, 0.62

Size: B 0.33 CI: 95% CI 0.04, 0.62
PMC7857648
Finding details → · Paper → · Graph →
None
decline

Presence of MSIMI at baseline was associated with 33% greater increase in Trail-B score over 2 years of follow-up, indicating faster executive function decline, and this association was partly mediate

Effect: decline; B 0.33; CI: 95% CI 0.04, 0.62

Size: B 0.33 CI: 95% CI 0.04, 0.62
PMC7857648
Finding details → · Paper → · Graph →
None
decline

Presence of MSIMI at baseline was associated with 33% greater increase in Trail-B score over 2 years of follow-up, indicating faster executive function decline, and this association was partly mediate

Effect: decline; B 0.33; CI: 95% CI 0.04, 0.62

Size: B 0.33 CI: 95% CI 0.04, 0.62
PMC7857648
Finding details → · Paper → · Graph →
None
decline

Presence of MSIMI at baseline was associated with 33% greater increase in Trail-B score over 2 years of follow-up, indicating faster executive function decline, and this association was partly mediate

Effect: decline; B 0.33; CI: 95% CI 0.04, 0.62

Size: B 0.33 CI: 95% CI 0.04, 0.62
PMC7857648
Finding details → · Paper → · Graph →
None
decline

Presence of MSIMI at baseline was associated with 33% greater increase in Trail-B score over 2 years of follow-up, indicating faster executive function decline, and this association was partly mediate

Effect: decline; B 0.33; CI: 95% CI 0.04, 0.62

Size: B 0.33 CI: 95% CI 0.04, 0.62
PMC7857648
Finding details → · Paper → · Graph →

Papers (1)